>. For a generic insulin to get FDA approval it needs bioequivalence which is a lot like running the original safety and effect studies over again That is inco

>. For a generic insulin to get FDA approval it needs bioequivalence which is a lot like running the original safety and effect studies over again That is incorrect. A bioequivalence study is much simpler and cheaper than the original safety and efficacy studies. You do not need to prove that safety and efficacy of the drug, only that you are delivering the equivalent of the originally studied drug at the same doses. https://en.wikipedia.org/wiki/Bioequivalence https://en.wikipedia.org/wiki/Bioequivalence